SARISSA BIOMEDICAL LIMITED

Dissolved Southampton

Manufacture of basic pharmaceutical products

Life sciences and medical technology Manufacture of basic pharmaceutical products
S

SARISSA BIOMEDICAL LIMITED

Manufacture of basic pharmaceutical products

Founded 4 Nov 2002 Dissolved Southampton, United Kingdom website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Due 30 Sept 2021 56 months overdue
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O James Cowper Kreston The White Building 1-4 Cumberland Place Southampton SO15 2NP

Telephone

0800 000 0000

Website

www.example.com

Full company profile for SARISSA BIOMEDICAL LIMITED (04581254), a dissolved life sciences and medical technology company based in Southampton, United Kingdom. Incorporated 4 Nov 2002. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 December 2020
Due by 30 September 2021 56 months overdue

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (27)

Mercia Fund 1
17.5%
199,919
Meif Proof Of Concept & Early Stage Lp
13.4%
153,202

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 1 Nov 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

The Mercia Fund 1

Ceased 1 Nov 2018

Ceased

Group Structure

Group Structure

SARISSA BIOMEDICAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026GazetteGazette Dissolved Liquidation
21 May 2025InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
14 Feb 2025InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
7 Feb 2025ResolutionResolutions
25 May 2023InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
2 Apr 2026 Gazette

Gazette Dissolved Liquidation

21 May 2025 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

14 Feb 2025 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

7 Feb 2025 Resolution

Resolutions

25 May 2023 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

3 weeks ago on 2 Apr 2026

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

11 months ago on 21 May 2025

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

1 years ago on 14 Feb 2025

Resolutions

1 years ago on 7 Feb 2025

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

2 years ago on 25 May 2023